The role of RNA methylations in the control of mRNA maturation and incorporation into polysomes has been investigated through a study of the effects in vivo of cycloleucine, a specific inhibitor of S-adenosyl-methionine mediated raethylation.
tn GpppXjjjY (cap 1) or m GpppX^Y,,, (cap 2) in which a 7-methyl guanosine group is linked to a 2'0 methylated nucleotide X^ by a 5'-5' triphosphate bond, o with a possible additional 2'0 methylation on the penultimate nucleotide Y .
The internal m A content of mRNA corresponds to about one residue per molecule whereas hnRNA, longer than mRNA contains about 4-6 times as many m A 5 9 per chain . The similarity of methylated sequences in mRNA and hnRNA and the conservative flow of methyl labelling in both 5' terminal caps and fi 9 internal m A from nucleus to cytoplasm strongly suggest a prominent role for methyl groups in the control of pre-mRNA processing. On the other hand, a series of in vitro translation studies have shown that terminal caps facili-
tate translational initiation of viral mRNAs '
In the present study, the characteristics of the production of polysomal poly(A) mRNAs as well as of presumptive pre-messenger poly(A) hnRNA were analyzed during an inhibition of RNA methylations. The rate of production of poly(A) + hnRNA was only slightly reduced during a cycloleucine treatment.
Conversely, undermethylated poly(A) + mRNA reached the cytoplasm in amounts very similar to control but with a longer lag-time after transcription. These molecules, possessing a non-methylated 5' terminal cap, were integrated into polysomes in proportions analogous to normally methylated messenger RNA.
MATERIALS AND METHODS
The material and methods used here are the same as described previously ' with the following additions and modifications.
P labelling conditions : Cells exponentially growing in monolayer were
washed with a prewarmed phosphate free Hanks basal saline solution and incubated for 2 hours in prewarmed phosphate-free low methionine medium. Cells 32
were labelled for 4 hours in the same prewarmed medium containing P phosphate (140 uCi/ml; 50 Ci/mg, Amersham England). Cycloleucine treatments (2 mg/ml) were begun 30 min before labelling.
Cell fractionation : Cells in monolayer were immediately detached with glass beads (0 0.25 -0.30 mm; B. Braun Melsungen) in R buffer (40 tnM Tris-HCl pH 7.7, 25 mM KC1,'4 mM MgCl-and 10 ug/ml polyvinylsulfate), in the presence of 0.5 % (v/v) cemulsol NPT 6 and 500 ug/ml collagenase. After 2 min handshaking in the cold (-••°C) , glass beads were discarded by decantation and the suspension containing the detached cells submitted to the action of an Ultra-1 2 Turrax to prepare nuclei as previously described . After elimination of mitochondria, the supernatant was added with sodium deoxycholate 1 % (w/v) and layered on a 30 % sucrose cushion in the same medium (1/3 v/ 2/3 v) and centrifuged 100 min at 50,000 rev/min in a Spinco Ti 50 rotor. The resulting pellet was essentially composed of polysomes + ribosomes. The supernatant was called soluble fraction.
RNA extraction and analysis : Ribosomal pellets were resuspended at 4°C in Tris 50 mM (pH 7.4) -EDTA 10 mM -1 % SDS and the solution incubated 1 hour at 20°C in presence of 200 ug/ml Proteinase K (Merck) . An equal volume of water satured phenol-chloroform (1 v/v) was added and the mixture vigourously shaken for 10 min at 20°C. After centrifugation, the aqueous phase was reextracted one more time with phenol-chloroform. After addition of NaCl (0.2 M final) the RNA was precipitated with 2 volumes of cold ethanol and allowed to stand overnight at -20°C before analysis. RNA was then fractionated into poly(A) and poly(A) RNA by two consecutive passages through oligo (dT)-cellulose columns , one of which after heat denaturation of RNA 5 min at 70 C at low ionic strength.
Nuclear RNA was first extracted from pelleted nuclei as described above for polysomal RNA. After ethanol precipitation and redissolution in TMK buffer, deproteinized nuclear RNA was treated by 100 jig/ml pancreatic DNase I (Worthington), 1 h. at 0°C, then once more extracted by phenolchloroform after proteinase K treatment in the presence of 1 % SDS. After ethanol precipitation and redissolution in 0.12 M NaCl, 1 mM EDTA, 10 mM In a preliminary experiment, the overall extent of RNA methylation in the absence or presence of cycloleucine was determined through pulse-labellingwith (methyl-H) methionine. As shown in Table 1 , the amount of (methyl-H) labelling recovered in extensively purified total cellular RNA of cycloleucine treated CHO cells corresponded only to about 5 % of the control level, while the rate of ( H) uridine incorporation was only slightly reduced (70 % of control cells) .
However, this result did not give an insight on mRNA methylation since we previously observed that most of RNA methyl groups of CHO cells were located either in rRNA or in tRNA molecules. Consequently, a direct titration of methylation was performed on total poly(A) RNA. Highly purified RNA was fractionated into poly(A) and poly(A) RNAs by two consecutive runs on oligo(dT) cellulose column. Our experimental procedure involved a denaturation step at low ionic strength before chromatography and allowed the obtention of poly(A) RNA devoid of any detectable rRNA contamination. As shown (3.7 %) Four identical cultures in Falcon flasks (containing 10 cells) were pulse-labelled for 30 min with (^H) uridine (40 uCi/ml; 40 Ci/nmol) or for 20 min with (methyl-^H) methionine (25 jiCi/ml; 5 Ci/mmol) either in the absence or presence of 2 mg/ml cycloleucine. Total cellular RNA were extracted, purified and separated into poly(A) and poly(A)~ fractions by oligo(dT) cellulose chromatography. The radioactivity recovered in the various fractions was normalized for identical number of cells and corrected for slight variations in the yield of RNA recovery through purification procedure, by 260 nm O.D. determinations before oligo(dT) fractionation.
in Table I We studied the fate of these labelled molecules during a chase experiment performed in the presence of cold uridine. As previously reported , an efficient blocking of ( H) uridine incorporation into RNA was achieved during the chase following a 30 min pulse with the radioactive precursor.
Poly(A) and poly(A) RNA labellings were mesured for varying chase times. For both nuclear RNA classes, a decrease in radioactivity was observed in cycloleucine treated and control cells (Fig. 1) . In control cells, the 50 % decay for poly(A) nuclear RNA was reached after about 120 min (Fig la) : it corresponded mainly to the maturation and export of rihosomal RNA to cytoplasm. In The size distribution of poly(A) hnRNA labelled during a one hour ( H) uridine pulse was analyzed by sucrose gradient sedimentation under denaturing conditions (Fig. 2 ) . No dramatic differences between cycloleucine treated and control cells poly(A) RNA size spectrum were revealed by analysis of the radioactivity profiles; however, a significant shift towards the high molecular weights was clearly seen when RNA methylation was inhibited.
Conversely, the size distribution of both treated and control cell poly(A) nuclear RNA became perfectly superimposable, when the one-hour pulse label with ( H) uridine was chased for two hours in the presence of unlabelled precursor (result not shown).
Effects of cycloleucine on mRNA integration into polysor-es
In a preliminary experiment (results not shown), we observed that neither the cytoplasmic ribosome content nor the size distribution of polysomes were significantly modified by cycloleucine, at least during the first 3 hours of treatment : two identical batches of cells were labelled with equal almost superimposable radioactivity profiles were obtained for both isotopes.
In a second set of experiments,we have examined the cytoplasmic appearance of labelled poly(A) RNA during a chase following a 30 min pulse with ( H) uridine. In Fig. 3b , we have plotted the poly(A) RNA radioactivity recovered in ribosomal (from monomer to polysomes) fraction; nearly all the radioactive cytoplasmic poly(A) RNA was located in this fraction for both treated and control cells. After a 30 min. pulse, the amount of cytoplasmic poly(A) RNA labelling in cycloleucine-treated cells corresponded to about 40 % of the control level. However, an important recovery of this inhibition was observed for longer chase time : a value exceeding 80 % of the control was reached after 210 min of chase. It is worth mentioning that throughout the chase experiment, the distribution of cytoplasmic poly(A) RNA between ribosomal and "soluble" fractions was not modified, the content of the latter fraction being almost negligible.
As previously reported , a dramatic decrease in the cytop'asnic appearance of poly(A) RUA (that is p>ainly rRNA) w->s observed during the cycloleucine treatment ( fig. 3a) .
From the data of fig. 1b and 3b , the proportion of poly(A) RNA radioactivity in uyrloleucine treated cells relative to control cells has been calculated. Results corresponding to nuclei,polysoraes and total cell respectively were plotted in fig. 4 . An analogous evolution was observed for both subcellular fractions during the chase time, with a continuous increase in the relative content of poly(A) RNA. However, a significant shift was observed between curves corresponding to nuclear and cytoplasmic RNAs, suggesting that newly synthesized poly(A) nuclear RNA was exported to cytoplasm with a delay during an inhibition of RNA methylations. It must be noted that the deficiency of whole cycloleucine-treated cell in poly(A) RNA gradually disappeared during the |>ult>e-chase experiment to reach control value after 210 min.
In the above described experiments, RNA was extracted from a total ribosomal pellet containing the most part of free mono-ribosomes in addition FIflURE 3 -Cycloleucine effects on labelled RNA appearance into poiysomal fraction during a pulse-chase Same experimental procedure as in Fig. 1 , RNA was extracted from the ribosomal pellet and analyzed as uescribed in Materials and Methods. a) poly(A)" RNA. The amount of RNA present in each sample has been determined by optical density measurement and the RNA specific activity (cpm/jjg) plotted. Table 2 .
The amount of poly(A) RNA radioactivity was measured in the 3 "pooled" areas termed A, B and C, containing respectively polysomes, disomes + monosomes, and elements sedimenting at less than 50S. The results of Table 2 clearly show that the distribution of poly(A) RNA among these areas was unaffected by the cycloleucine treatment. For both treated and control cells, it is worth observing that the major part of poly(A) RNA was actually recovered in the "A" (polysomes) fraction, for the two chase times studied. In another experiment (results not shown), the "A" area was further fractionated into 100.
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Fraction number FIGURE 5 -Polysomes distribution after a cycloleucine treatment Cells were prelabelled for 16 hours with ( C) uridine (0.03 uCi/ml, 0.4 Ci/mmol). Thirty minutes after cycloleucine addition (2 mg/ml) , cells were pulsed for 1 hour with ( H) uridine (20 uCi/mmol) and chased for 30 min in the presence of unlabelled uridine. Cells were harvested and a post-mitochondrial supernatant (see Materials and Methods) was isolated, added with DOC (1 % final) and analyzed onto a 15 -30 % sucrose gradient (in TKM buffer), by a 30 min run at 49,000 RPM (rotor Spinco SW 50.1)-Aliquots of the collected fractions were assayed for radioactivity content. S values were determined from a run of rat liver ribosomal subunits in a parallel gradient. two sub-regions corresponding to elements sedimenting faster or slower than 160S. In this case again, no differences were observed in the quantitative repartition of labelled poly(A) RNA.
Finally, it must be pointed out that the cycloleucine treatment 3 resulted in a significantly increased proportion of oligo(dT)-bound ( H) RNA in the "A" and "B" fractions of the polysomes gradient, due to the drastic inhibition on the appearance of poly(A) RNA (mainly rRNA), as elsewhere (77) 3,230 (14) 1 ,910 (9) 22,740 (100) oly ( (55) 16,000 (24) 14,300 (21) 66,500 (100) , Same experiment as described in Fig. 5 . After the one-hour pulse with ( H) uridine, cells were chased for 30 min or 2 hours. Control cells were similarly pulse-chased in the absence of cycloleucine. Fractions from the sucrose gradients were pooled in three batches, A (large polysomes), B (disomes + monosomes), and C (soluble fractions) as shown in fig. 5 . After a proteinase K treatment and a phenol-chloroform extraction, RNA was precipitated by ethanol. RNA was then fractionated in poly(A) + and poly(A)~ RNAs by chromatography on oligo(dT) cellulose column. The ('*C) uniform prelabelling of RNA has permitted corrections for slight variations in the RNA recovery between different samples during all fractionation and RNA purification. The extent of poly(A) RNA methylation during a cycloleucine treatment was determined after a 20 min pulse labelling of CHO cells with (methyl H) methionine as described in Table 3 . In these conditions, one must expect that an important fraction of the poly(A) RNA labelling in cytoplasm corresponds in fact to the late 2'-0 methylation in Y position ' . As it is shown in table 3, poly(A) RNA methylations were extensively inhibited in the 10 cells were pulse labelled 20 min with ( H) methionine (25 uCi/ml; 5 Ci/imnol) RNAs were extracted from nuclei and ribosomes highly purified, then fractionated into poly(A)~ and poly(A) + RNA. Radioactivity has been normalized for identical number of cells taking into account slight variations in the RNA recovery. A special care has been used for radioactivity determination due to the low level of poly (A) + RNA labelling. The sample counting time was long enough to register at least 10^ desintegrations.For each vial actual background was determined by precounting.
presence of cycloleucine in both subcellular compartments : only 3-4 % residual labelling were detected in nuclear or cytoplasmic poly(A) RNA. It thus appears that all types of methyl additions on mRNA molecules,including late cytoplasmic methylations,were equally inhibited by cycloleucine.
Analysis of 5' terminal caps in polysomal poly(A) RNA
Since the addition of methyl groups on poly(A) hnRNA and cytoplasmic poly(A) mRNA was almost suppressed in the presence of cycloleucine, it could be asked whether the 5' terminal blocked "caps" were still present on undermethylated polysomal poly(A) mRNA. This question was examined by an 32 " * " analysis of an RNase T2 digest of ( P) long labelled polysomal poly(A) RNA I Q on a DBAE-cellulose column, a procedure previously described by Furuichi for the separation of the capped ends from the bulk of internal nucleotides and phosphorylated 5' non-capped termini ; this method depends on the selective affinity for DBAE of cis 2'-3' diols of the terminal (n )G. The RNase 32 CHO cells were labelled for 4 hours with ( P) orthophosphate (140 uCi/ml; 50 Ci/mg) in the presence or absence of cycloleucine (2 mg/ml). Polysomes were isolated, RNA extracted and poly(A) RNA purified as described in Materials and Methods. Nearly equal amounts of poly(A) + RNA were digested exhaustively with ribonuclease T2. The digest was then diluted with 10 vol DBAE application buffer '5 and applied to a 0.4 x 4 cm acetylated-DBAE cellulose column. After washing of the column with application buffer (60 ml), caps were eluted with 1 M sorbitol in the same buffer. Total counts in nucleotides and caps were determined. Values into brackets are percent of total counts recovered into caps. Our results clearly establish that none of fhe 3 or 4 methyl groups generally found in eucaryotic messenger RNA is stringently required for the production of functional mRNA. However the lack of methylation is correlated to obvious perturbations in mRNA processing. As for the transcription level, a precise determination of the rate of synthesis of poly(A) hnRNA during the cycloleucine treatment is difficult to obtain, due to the superimposition of pre-rRNA molecules,as we have settled not to perform a selective block by low doses of Actinomycin D which could result in feed-back alterations in the 24 level of hnRNA production . However, we did not observe significant variations in the labelling of nuclear RNA molecules larger than 45S when CHO cells were pulsed for short periods with ( H) uridine in the presence of cycloleucine, which seems to indicate that the undermethylation does not induce drastic modifications in the biosynthesis rate of hnRNA.
As for the post-synthetic modifications of the pre-mRNA transcript in eucaryotic cells, one still lacks a detailed knowledge of the actual se-quence of tnaturational events(methylations, cleavage and splicing , poly-26 adenylation and protein binding). Anyhow, our results clearlv establish that hnRNA methylation is not necessary for its polyadenylation ; even if a light initial decrease in newly synthesized poly(A) hnRNA appearance was observed (15 %) in presence of cycloleucine. In mairenalian cells, hnRNA maturation is accompagnied by a decrease in the average size of precursor mole-1 cules .This processus, still unclear, was correlated to the reduction of the internal m A group number per molecule . Routinely, '/P observed that the average size of total poly(A) hnRNA was,for short given labelling tine, higher for undermethylated molecules than for normally methylated RNAs. It must be pointed out that the size distribution of both types of molecules became almost superimposable for prolonged periods of chase. Put together with the initial lag-time observed for the cytoplasmic appearance of unmethylated poly(A) RNA, these results could indicate that if m A in hnRNA are important for the kinetics of its processing, the presence of the methyl group does not play a key-role in the site specificity of the maturational cleavages.
Obviously, a more precise evaluation of the interaction between methylation and mRNA processing is difficult to be drawn from our present study performed on a complex population of messenger molecules. In order to gain a further insight onto this problem, we are now studying the production of a specific mRNA during an inhibition of RNA methylation by cycloleucine in Friend cells committed to differentiate.
